Trexquant Investment’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-499,715
| Closed | -$3.94M | – | 1697 |
|
|
2025
Q3 | $3.94M | Sell |
499,715
-352,660
| -41% | -$2.51M | 0.04% | 642 |
|
|
2025
Q2 | $4.88M | Buy |
852,375
+601,703
| +240% | +$3.88M | 0.06% | 538 |
|
|
2025
Q1 | $2.05M | Sell |
250,672
-715,377
| -74% | -$6.62M | 0.02% | 865 |
|
|
2024
Q4 | $9.1M | Buy |
966,049
+486,827
| +102% | +$5.06M | 0.11% | 301 |
|
|
2024
Q3 | $5.12M | Buy |
+479,222
| New | +$5.22M | 0.06% | 465 |
|
|
2023
Q4 | – | Sell |
-59,976
| Closed | -$729K | – | 1546 |
|
|
2023
Q3 | $729K | Buy |
+59,976
| New | +$774K | 0.02% | 875 |
|
|
2023
Q2 | – | Sell |
-267,931
| Closed | -$2.97M | – | 1552 |
|
|
2023
Q1 | $2.97M | Buy |
267,931
+129,447
| +93% | +$1.6M | 0.08% | 329 |
|
|
2022
Q4 | $1.69M | Buy |
+138,484
| New | +$1.56M | 0.05% | 472 |
|
|
2022
Q3 | – | Sell |
-27,077
| Closed | -$291K | – | 1518 |
|
|
2022
Q2 | $291K | Buy |
+27,077
| New | +$223K | 0.01% | 1139 |
|
|
2021
Q4 | – | Sell |
-11,782
| Closed | -$113K | – | 1404 |
|
|
2021
Q3 | $113K | Sell |
11,782
-18,643
| -61% | -$191K | 0.01% | 1041 |
|
|
2021
Q2 | $293K | Sell |
30,425
-49,368
| -62% | -$482K | 0.02% | 724 |
|
|
2021
Q1 | $788K | Buy |
79,793
+25,201
| +46% | +$390K | 0.07% | 344 |
|
|
2020
Q4 | $1.26M | Buy |
54,592
+34,008
| +165% | +$695K | 0.13% | 208 |
|
|
2020
Q3 | $291K | Buy |
+20,584
| New | +$300K | 0.02% | 935 |
|
|
2020
Q2 | – | Sell |
-35,155
| Closed | -$325K | – | 1256 |
|
|
2020
Q1 | $325K | Buy |
+35,155
| New | +$334K | 0.02% | 820 |
|
|
2019
Q4 | – | Sell |
-39,260
| Closed | -$315K | – | 1110 |
|
|
2019
Q3 | $315K | Sell |
39,260
-30,215
| -43% | -$328K | 0.03% | 601 |
|
|
2019
Q2 | $867K | Buy |
+69,475
| New | +$882K | 0.08% | 344 |
|
|
2018
Q2 | – | Sell |
-22,571
| Closed | -$339K | – | 993 |
|
|
2018
Q1 | $339K | Sell |
22,571
-2,690
| -11% | -$40.9K | 0.02% | 777 |
|
|
2017
Q4 | $364K | Buy |
25,261
+5,101
| +25% | +$70.1K | 0.04% | 653 |
|
|
2017
Q3 | $304K | Sell |
20,160
-22,240
| -52% | -$294K | 0.08% | 462 |
|
|
2017
Q2 | $427K | Sell |
42,400
-27,164
| -39% | -$219K | 0.12% | 309 |
|
|
2017
Q1 | $496K | Buy |
+69,564
| New | +$440K | 0.06% | 542 |
|
|
2016
Q4 | – | Sell |
-29,662
| Closed | -$219K | – | 1017 |
|
|
2016
Q3 | $219K | Sell |
29,662
-58,824
| -66% | -$397K | 0.05% | 601 |
|
|
2016
Q2 | $483K | Buy |
88,486
+65,720
| +289% | +$460K | 0.06% | 491 |
|
|
2016
Q1 | $192K | Buy |
+22,766
| New | +$161K | 0.02% | 847 |
|
|
2015
Q3 | – | Sell |
-115,100
| Closed | -$1.63M | – | 1103 |
|
|
2015
Q2 | $1.63M | Buy |
115,100
+50,100
| +77% | +$602K | 0.18% | 157 |
|
|
2015
Q1 | $707K | Sell |
65,000
-6,700
| -9% | -$59.1K | 0.07% | 537 |
|
|
2014
Q4 | $596K | Buy |
+71,700
| New | +$492K | 0.11% | 389 |
|
Other funds holding FOLD
HI
PCM
BG
PA
Trexquant Investment's FOLD Position: Q4 2025 in Review
Trexquant Investment sold out of Amicus Therapeutics (FOLD) in Q4 2025, closing a stake of 499,715 shares — an estimated $3.94M sold.
Trexquant Investment first reported a position in FOLD in Q4 2014 and held it in 28 quarters. The position peaked at $9.1M in Q4 2024. 332 funds tracked by Wall St. Rank hold FOLD as of Q4 2025.
- Trexquant Investment reported no remaining Amicus Therapeutics position as of Q4 2025 after selling out during the quarter.
- Trexquant Investment sold 499,715 Amicus Therapeutics shares in Q4 2025, an estimated $3.94M.
- Trexquant Investment first reported a position in Amicus Therapeutics in Q4 2014 and held it in 28 quarters.
- Trexquant Investment's Amicus Therapeutics position peaked at $9.1M in Q4 2024.
- 332 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2025.
Based on Trexquant Investment's 13F filing for Q4 2025, filed 17 Feb 2026.